The use of a medical nutrition supplement in patients with metastatic colorectal cancer

ABSTRACT: Interventions: The test group will be asked to take the medical nutrition supplement twice per day, during the first 3 cycles of CAPOX-B treatment. The control group receives the same medical treatment with CAPOX-B and standard of care. Primary outcome(s): To explore the compliance to nutritional test product intake Study Design: Randomized controlled trial, Open (masking not used), N/A , unknown, Parallel

DISEASE(S): Metastatic Colorectal Cancer Patients

PROVIDER: 20951 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR